Intensive Immunosuppression Therapy for Aplastic Anemia Associated with Dyskeratosis Congenita: Report of a Case

Abstract

Dyskeratosis congenita (DC) is a very rare inherited disorder characterized by skin pigmentation, nail dystrophy, and mucosal leukoplakia. It is also associated with a variety of noncutaneous abnormalities, such as fatal pulmonary complications, malignancy, and bone marrow failure. We report the case of a 32-year-old man with DC associated with severe aplastic anemia (SAA).The traditional treatment of DC-associated SAA is allogeneic hematopoietic stem cell transplantation (HSCT). However, in this case, an HLA-matched donor was not available. Therefore our patient was given intensive immunosuppressive therapy with antilymphocyte globulin (ALG) and cyclosporine A (CsA). The hemogram findings improved after the treatment, but the patient died of pulmonary complications after being in stable condition for 6 months. The results support the possible use of intensive immunosuppression with ALG and CsA for DC-associated SAA as an alternative treatment for patients who are not eligible for HSCT.

This is a preview of subscription content, log in to check access.

References

  1. 1.

    Dokal I. Dyskeratosis congenita.Br J Haematol. 1999;105(suppl1):11–155.

    PubMed  Google Scholar 

  2. 2.

    Knight S, Vulliamy T, Copplestone A, Gluckman E, Mason P, Dokal I. Dyskeratosis congenita (DC) registry: identification of new features of DC.Br J Haematol. 1998;103:990–996.

    Article  CAS  Google Scholar 

  3. 3.

    Dokal I. Dyskeratosis congenita in all its forms.Br J Haematol. 2000;110:768–779.

    Article  CAS  Google Scholar 

  4. 4.

    Langston AA, Sanders JE, Deeg HJ, et al. Allogeneic marrow transplantation for aplastic anemia associated with dyskeratosis congenita.Br J Haematol. 1996;92:758–765.

    Article  CAS  Google Scholar 

  5. 5.

    Bacigalupo A, Bruno B, Saracco P, et al. Antilymphocyte globulin, cyclosporine, prednisolone, and granulocyte colony-stimulating factor for severe aplastic anemia: an update of the GITMO/EBMT study on 100 patients. European Group for Blood and Marrow Transplantation (EBMT) Working Party on Severe Aplastic Anemia and the Gruppo Italiano Trapianti di Midolio Osseo (GITMO).Blood. 2000;95:1931–1934.

    PubMed  PubMed Central  CAS  Google Scholar 

  6. 6.

    Kawano Y, Nissen C, Gratwohl A, Speck B. Immunostimulatory effects of different antilymphocyte globulin preparations: a possible clue to their clinical effect.Br J Haematol. 1988;68:115–119.

    Article  CAS  Google Scholar 

  7. 7.

    Bacigalupo A, Broccia G, Corda G, et al. Antilymphocyte globulin, cyclosporin, and granulocyte colony-stimulating factor in patients with acquired severe aplastic anemia (SAA): a pilot study of the EBMT SAA Working Party.Blood. 1995;85:1348–1353.

    PubMed  PubMed Central  CAS  Google Scholar 

  8. 8.

    Knight SW, Vulliamy TJ, Heiss NS, et al. 1.4Mb candidate gene region for X-linked dyskeratosis congenita defined by combined haplotype and X-chromosome inactivation analysis.J Med Genet. 1998;35:993–996.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. 9.

    Yilmaz K, Inaloz HS, Unal B, Guler E. Dyskeratosis congenita with isolated neutropenia and granulocyte colony-stimulating factor treatment.Int J Dermatol. 2002;41:170–172.

    Article  Google Scholar 

  10. 10.

    Yabe M, Yabe H, Hattori K, et al. Fatal interstitial pulmonary disease in a patient with dyskeratosis congenita after allogeneic bone marrow transplantation.Bone Marrow Transplant. 1997;19:389–3922.

    Article  CAS  Google Scholar 

  11. 11.

    Rocha V, Devergie A, Socie G, et al. Unusual complications after bone marrow transplantation for dyskeratosis congenita.Br J Haematol. 1998;103:243–248.

    Article  CAS  Google Scholar 

Download references

Author information

Affiliations

Authors

Corresponding authors

Correspondence to Patrizia Comoli or Sabrina Basso or Guan-Cheng Huang.

About this article

Cite this article

Comoli, P., Basso, S. & Huang, G. Intensive Immunosuppression Therapy for Aplastic Anemia Associated with Dyskeratosis Congenita: Report of a Case. Int J Hematol 82, 35–37 (2005). https://doi.org/10.1532/IJH97.A10416

Download citation

Key words

  • Dyskeratosis congenita
  • Aplastic anemia
  • Antilymphocyte globulin
  • Immunosuppression therapy